The French association of animal health industry (SIMV)
The SIMV represents manufacturers and marketers (on the French market) of medicines and reagents for pets and for farm animals. It is the DNA that runs through our entire industry, at the core of many of our interactions.
France is the European leader in research and manufacture of veterinary medicines and reagents, with over 6,600 employees, and the largest therapeutic arsenal in Europe (2,700 marketing authorisations), 50 production sites and many research centers. The global attractiveness of France in matters of animal health lies in the density of this industrial, veterinary, and professional fabric, in its recognized scientific and technical expertise, and in the capacity of its manufacturers to invest in managing networked R&D projects and international projects.
To contribute to the competitiveness of its member companies, the SIMV federates laboratories around joint projects, proposes collective strategies in response to the expectations of society and represents the views of its members in its decision-making environment.
Our members annually invest 10-12% of their turnover on research and development (R&D).
With the ambition to contribute to highlight the innovations of tomorrow, the SIMV is a member of networks such as the French Network for Animal Health (RFSA), mirror group of the European Platform (ETPGAH), Hippolia (French foundation dedicated to equine research), ICSA (Animal Health Carnot Institute) as well as ARIIS (French Alliance for Research and Innovation of Health Industries).